All Stories

  1. Current developments and future directions in COPD
  2. A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
  3. Laboratory Cross-Contamination of Mycobacterium tuberculosis: A Systematic Review and Meta-analysis
  4. Transfusion-Transmitted Malaria: A Systematic Review and Meta-analysis
  5. How do clinical trials on COPD exacerbations evaluate the effect treatments have on patients?
  6. Was the implementation strategy of the ProACT trial adequately proactive?
  7. Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services
  8. Research highlights from the 2018 European Respiratory Society International Congress: airway disease
  9. Intermittent prophylactic antibiotics for bronchiectasis
  10. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs [Erratum]
  11. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis
  12. Biomarkers to guide antibiotic therapy for COPD exacerbations
  13. Capsule Commentary on Ashburner et al., Electronic Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation: a Randomized Controlled Trial
  14. What is the impact of GOLD 2017 recommendations in primary care? – a descriptive study of patient classifications, treatment burden and costs
  15. EARLY versus MILD Chronic Obstructive Pulmonary Disease (COPD)
  16. Continuous versus intermittent antibiotics for bronchiectasis
  17. COPD and Stroke
  18. The emerging Chinese COPD epidemic
  19. Capsule Commentary on Bremmer et. al., Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations
  20. Research highlights from the 2017 ERS International Congress: airway diseases in focus
  21. Early Career Members at the ERS International Congress 2017: highlights from the Assemblies
  22. Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis
  23. Airways diseases: insights from the European Respiratory Society Annual Congress 2017
  24. ERS Early Career Members meet EAACI Junior Members: the launch of a strong, fruitful collaboration
  25. Continuous versus intermittent antibiotics for non-cystic fibrosis bronchiectasis
  26. GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence
  27. Interventions to improve inhaler technique and adherence to inhaled corticosteroids in children with asthma
  28. Opportunities for early career members
  29. Relationship of Allergy with Asthma: There Are More Than the Allergy “Eggs” in the Asthma “Basket”
  30. Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
  31. Interventions to improve inhaler technique for people with asthma
  32. Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
  33. Early Career Members at the ERS International Congress London 2016
  34. How to keep good clinical records
  35. Prevalence and burden of comorbidities in COPD
  36. Valvular-CHADS-VASc as a safer alternative to CHADS-VASc score
  37. Serum procalcitonin can guide antibiotic administration for respiratory tract infections in primary care
  38. Obstructive Sleep Apnea and Hypertension: A Bidirectional Causal Relation
  39. Overlap Syndrome of Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnoea
  40. The risk of tachyarrhythmias in patients with moderate-to-severe chronic kidney disease receiving tiotropium bromide
  41. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations
  42. Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: Are they equivalent?
  43. COPD Phenotypes and Biomarkers: Introducing Personalised Medicine
  44. Management of Stable COPD: An Update
  45. Editorial from Guest Editor (Thematic Issue: Current Approach to COPD Management: Setting a Model in Medical Therapeutics)
  46. Tiotropium HandiHaler Improves the Survival of Patients with COPD: A Systematic Review and Meta-Analysis
  47. Drugs that Act on the Respiratory Tract
  48. Expression of Bmi1, FoxF1, Nanog, and γ-Catenin in Relation to Hedgehog Signaling Pathway in Human Non-small-Cell Lung Cancer
  49. Tiotropium Inhaler Devices: Seeking Convenience When Mortality Is at Stake?
  50. Impact of long‐term treatment with low‐dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: Aggravating or beneficial?
  51. Chronic bronchitis: an objective diagnosis of exclusion